References
- 1. G. McCartney, F. Popham, R. McMaster and A. Cumbers, Defining health and health inequalities, Public Health 172 (2019) 22–30; https://doi.org/10.1016/j.puhe.2019.03.023
- 2. F. Tohidinezhad, A. Khorsand, S. R. Zakavi, R. Rezvani, S. Z. Ghanavati, M. Abrishami, A. Moradi, M. Tavakoli, D. Farrokh, M. P. Rad, B. Abbasi, M. Ahadi, L. A. Saleh, M. Tayebi, M. Amini, H. Poustchi, A. A. Hanna and S. Eslami, The burden and predisposing factors of non-communicable diseases in Mashhad University of Medical Sciences personnel: a prospective 15-year organizational cohort study protocol and baseline assessment, BMC Public Health 20(1) (2020) Article ID 1637 (15 pages); https://doi.org/10.1186/s12889-020-09704-3
- 3. P. Rarau, S. Guo, S. N. Baptista, J. Pulford, B. McPake and B. Oldenburg, Prevalence of non-communicable diseases and their risk factors in Papua New Guinea: A systematic review, SAGE Open Med. 8 (2020) 1–14; https://doi.org/10.1177/2050312120973842
- 4. L. Li, C. Wu, Y. Gan, X. Qu and Z. Lu, Insomnia and the risk of depression: a meta-analysis of prospective cohort studies, BMC Psychiatry 16(1) (2016) Article ID 375 (16 pages); https://doi.org/10.1186/s12888-016-1075-3
- 5. L. Yue, R. Zhao, Q. Xiao, Y. Zhuo, J. Yu and X. Meng, The effect of mental health on sleep quality of front-line medical staff during the COVID-19 outbreak in China: A cross-sectional study, PLoS One 16(6) (2021) e0253753 (14 pages); https://doi.org/10.1371/journal.pone.0253753
- 6. G. Richter, V. W. Y. Liao, P. K. Ahring and M. Chebib, The Z-drugs zolpidem, zaleplon, and eszopi-clone have varying actions on human GABAA receptors containing γ1, γ2, and γ3 subunits, Front. Neurosci. 14 (2020) Article ID 599812 (12 pages); https://doi.org/10.3389/fnins.2020.599812
- 7. M. Horowitz, Antidepressant and anxiolytic-like, sedation and hypnosis, J. Basic Clin. Physiol. Pharmacol. 28(2) (2017) 91–92; https://doi.org/10.1515/jbcpp-2017-0022
- 8. T. C. Neylan, A. Richards, T. J. Metzler, L. M. Ruoff, J. Varbel, A. O’Donovan, M. Sivasubramanian, T. Motraghi, J. Hlavin, S. L. Batki, S. S. Inslicht, K. Samuelson, S. R. Morairty and T. S Kilduff, Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial, Sleep 43(10) 2020 Article ID zsaa080 (31 pages); https://doi.org/10.1093/sleep/zsaa080
- 9. T. S. Schepis, C. J. Teter, L. Simoni-Wastila and S. E. McCabe, Prescription tranquilizer/sedative misuse prevalence and correlates across age cohorts in the US, Addict Behav. 87 (2018) 24–32; https://doi.org/10.1016/j.addbeh.2018.06.013
- 10. S. Siafis, J. M. Davis and S. Leucht, Antipsychotic drugs: from ‘major tranquilizers’ to neuroscience-based-nomenclature, Psychol. Med. 51(3) (2021) 522–524; https://doi.org/10.1017/S0033291719003957
- 11. N. T. Vozoris and R. S. Leung, Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data, Sleep 34(7) (2011) 869–874; https://doi.org/10.5665/SLEEP.1116
- 12. J. L. Schroeck, J. Ford, E. L. Conway, K. E. Kurtzhalts, M. E. Gee, K. A. Vollmer and K. A. Mergenhagen, Review of safety and efficacy of sleep medicines in older adults, Clin. Ther. 38(11) (2016) 2340–2372; https://doi.org/10.1016/j.clinthera.2016.09.010
- 13. N. Buscemi, B. Vandermeer, C. Friesen, L. Bialy, M. Tubman, M. Ospina, T. P. Klassen and M. Wit-mans, The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs, J. Gen. Intern. Med. 22(9) (2007) Article ID 1335; https://doi.org/10.1007/s11606-007-0251-z
- 14. J. D. Di Vincenzo, A. Siegel, O. Lipsitz, R. Ho, K. M. Teopiz, J. Ng, L. M. W. Lui, K. Lin, B. Cao, N. B. Rodrigues, H. Gill, R. S. McIntyre and J. D. Rosenblat, The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review, J. Psychiatr. Res. 137 (2021) 232–241; https://doi.org/10.1016/j.jpsychires.2021.02.05
- 15. R. R. Dalacorte, J. C. Rigo and A. Dalacorte, Pain management in the elderly at the end of life, North Am. J. Med. Sci. 8(3) (2011) 348–354; https://doi.org/doi:10.4297/najms.2011.3348
- 16. B. K. Alldredge, A. M. Gelb, S. M. Isaacs, M. D. Corry, F. Allen, S. Ulrich, M. D. Gottwald, N. O’Neil, J. M. Neuhaus, M. R. Segal and D. H. Lowenstein, A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus, N. Engl. J. Med. 345(9) (2001) 631–637; https://doi.org/10.1056/NEJMoa002141
- 17. H. R. Cock and A. H. V. Schapira, A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus, QJM 95(4) (2002) 225–231; https://doi.org/10.1093/qjmed/95.4.225
- 18. C. M. Morin, C. H. Bastien, D. Brink and T. R. Brown, Adverse effects of temazepam in older adults with chronic insomnia, Hum. Psychopharmacol. 18(1) (2003) 75–82; https://doi.org/10.1002/hup.454
- 19. R. C. Voshaar, A. J. van Balkom and F. G. Zitman, Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study, Eur. Neuropsychopharmacol. 14(4) (2004) 301–306; https://doi.org/10.1016/j.euroneuro.2003.09.007
- 20. G. V. Pramod, P. Shambulingappa, M. C. Shashikanth and S. Lele, Analgesic efficacy of diazepam and placebo in patients with temporomandibular disorders: a double blind randomized clinical trial, Indian J. Dent. Res. 22(3) (2011) 404–409; https://doi.org/10.4103/0970-9290.87062
- 21. K. Pokharel, M. Tripathi, P. K. Gupta, B. Bhattarai, S. Khatiwada and A. Subedi, Premedication with oral alprazolam and melatonin combination: a comparison with either alone-a randomized controlled factorial trial, Biomed. Res. Int. 2014 (2014) Article ID 356964 (16 pages); https://doi.org10.1155/2014/356964
- 22. J. Puustinen, R. Lähteenmäki, J. Nurminen, T. Vahlberg, P. Aarnio, M. Partinen, I. Räihä, P. J. Neuvonen and S.-L. Kivelä, Long-term persistence of withdrawal of temazepam, zopiclone, and zolpidem in older adults: a 3-year follow-up study, BMC Geriatr. 18(1) (2018) Article ID 142 (21 pages); https://doi.org/10.1186/s12877-018-0829-9
- 23. J. C. Carberry, L. P. Fisher, R. R. Grunstein, S. C. Gandevia, D. K. McKenzie, J. E. Butler and D. J. Eckert, Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem, Eur. Respir. J. 50(6) (2017) Article ID 1701344 (11 pages); https://doi.org/10.1183/13993003.01344-2017
- 24. S. Guo, V. Manning, Y. Yang, P. K. Koh, E. Chan, N. N. de Souza, P. N. Assam, R. Sultana, R. Wijesinghe, J. Pangjaya, G. Kandasami, C. Cheok, K. M. Lee and K. E. Wong, Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore, J. Subst. Abuse Treat. 91 (2018) 1–11; https://doi.org/10.1016/j.jsat.2018.04.012
- 25. J. Wang, Z. Wang, X. Wang, G. Du, B. Zheng, Y. Li and Q. Wang, Combination of alprazolam and bailemian capsule improves the sleep quality in patients with post-stroke insomnia: A retrospective study, Front. Psychiatry 10 (2019) Article ID 411 (6 pages); https://doi.org/10.3389/fpsyt.2019.00411
- 26. D. Nene, R. C. Mundlamuri, P. Satishchandra, P. V. Prathyusha, M. Nagappa, P. S. Bindu, K. Raghavendra, J. Saini, R. D. Bharath, K. Thennarasu, A. B. Taly and S. Sinha, Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): A prospective randomized controlled pilot study, Seizure 65 (2019) 111–117; https://doi.org/10.1016/j.seizure.2019.01.015
- 27. D. Hackett, V. Haudiquet and E. Salinas, A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder, Eur. Psychiatry 18(4) (2003) 182–187; https://doi.org/10.1016/s0924-9338(03)00046-4
- 28. M. S. Asghar, M. N. Ahsan, R. Jawed, U. Rasheed, S. A. A. Naqvi, M. Hassan, R. Yaseen, N. Mallick, M. Zehra and M. A. Saleem, Comparative the use of alprazolam and melatonin for sleep disturbances in hemodialysis patients, Cureus 12(11) (2020) e11754 (8 pages); https://doi.org/10.7759/cure-us.11754
- 29. H. A. Kamdar, M. Hamed, K. S. Smetana, K. Shanmugam, E. Peters, R. Yasin, G. Thakur, M. Gopal, K. Sawalha, D. Greene-Chandos and O. Hussein, Lorazepam timing for acute convulsive seizure control (LoTASC), Seizure 83 (2020) 41–47; https://doi.org/10.1016/j.seizure.2020.09.024
- 30. S. Huo, L. Cheng, S. Li and F. Xu, Effects of eszopiclone on sleep quality and cognitive function in elderly patients with Alzheimer’s disease and sleep disorder: A randomized controlled trial, Brain Behav. 12(2) (2022) e2488 (7 pages); https://doi.org/10.1002/brb3.2488
- 31. E. Mešanović, Ć. Habul and E. Hadžić, Clinical efficacy of diazepam after whiplash: a randomized controlled study, Med. Glas. (Zenica) 19(1) (2022) (6 pages); https://doi.org/10.17392/1436-21
- 32. P. S. Masand, Side effects of antipsychotics in the elderly, J. Clin. Psychiatry 61 (2000) 43–49.
- 33. E. Rogers, S. Mehta, R. Shengelia and M. C. Reid, Four strategies for managing opioid-induced side effects in older adults, Clin. Geriatr. 21(4) (2013) http://www.consultant360.com/articles/four-strategies-managing-opioid-induced-side-effects-older-adults
- 34. G. M. Tawfik, K. A. S. Dila, M. Y. F. Mohamed, D. N. H. Tam, N. D. Kien, A. M. Ahmed and N. T. Huy, A step by step guide for conducting a systematic review and meta-analysis with simulation data, Trop. Med. Health 47 (2019) Article ID 46 (9 pages); https://doi.org/10.1186/s41182-019-0165-6
- 35. D. Jackson, M. Law, J. K. Barrett, R. Turner, J. P. Higgins, G. Salanti and I. R. White, Extending Der-Simonian and Laird’s methodology to perform network meta-analyses with random inconsistency effects, Stat. Med. 35 (2016) Article ID 6 (18 pages); https://doi.org/819-39.10.1002/sim.6752
- 36. O. Efthimiou, G. Rücker, G. Schwarzer, J. P. T. Higgins, M. Egger and G. Salanti, Network meta-analysis of rare events using the Mantel-Haenszel method, Stat. Med. 38(16) (2019) 2992–3012; https://doi.org/10.1002/sim.8158
- 37. J. P. T. Higgins and S. Green (Eds.), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011; https://www.cochrane-handbook.org; last access April 10, 2022
- 38. S. Buccheri, G. H. Sodeck and D. Capodanno, Statistical primer: methodology and reporting of meta-analyses, Eur. J. Cardiothorac. Surg. 53(4) (2018) 708–713; https://doi.org/10.1093/ejcts/ezy004
- 39. M. Alavi, G. E. Hunt, D. C. Visentin, R. Watson, D. K. Thapa and M Cleary, Seeing the forest for the trees: How to interpret a meta-analysis forest plot, J. Adv. Nurs. 77(3) (2021) 1097–1101; https://doi.org/10.1111/jan.14721
- 40. M. Viswanathan, C. D. Patnode, N. D. Berkman, E. B. Bass, S. Chang, L. Hartling, M. H. Murad, J. R. Treadwell and R. L. Kane, Recommendations for assessing the risk of bias in systematic reviews of health-care interventions, J. Clin. Epidemiol. 97 (2018) 26–34; https://doi.org/10.1016/j.jclinepi.2017.12.004
- 41. J. Chen, H. Ye, J. Zhang, A. Li and Y. Ni, Pathogenesis of seizures and epilepsy after stroke, Acta Epileptolog. 4 (2022) Article ID 2 (6 pages); https://doi.org/10.1186/s42494-021-00068-8
- 42. J. G. Jefferys, Advances in understanding basic mechanisms of epilepsy and seizures, Seizure 19(10) (2010) 638–646; https://doi.org/10.1016/j.seizure.2010.10.026
- 43. C. M. Morin, D. C. Jarrin, H. Ivers, C. Mérette, M. LeBlanc and J. Savard, Incidence, persistence, and remission rates of insomnia over 5 years, JAMA Netw. Open 3(11) (2020) e2018782 (11 pages); https://doi.org/10.1001/jamanetworkopen.2020.18782
- 44. L. Waters, K. Cameron, S. K. Nelson-Coffey, D. L. Crone, M. L. Kern, T. Lomas, L. Oades, R. L. Owens, J. O. Pawelski, T. Rashid, M. A. Warren, M. A. White and P. Williams, Collective wellbeing and posttraumatic growth during COVID-19: how positive psychology can help families, schools, workplaces and marginalized communities, J. Pos. Psychol. 16 (2021); https://doi.org/10.1080/17439760.2021.1940251
- 45. S. E. Cho, S. G. Kang and K. S. Na, An elderly bias, nocturia, and adverse effects of sedative-hypnotic medication, JAMA Intern. Med. 179(10) (2019) 1443–1444; https://doi.org/10.1001/jamainternmed.2019.4024